RNA Outsourcing Resources
-
Enhancing Preclinical Analytics to Drive Clinical Success
12/9/2025
Bioanalysis is crucial for biopharma success. Here, Dash Bio’s Ander Tallett discusses selecting a bioanalysis CRO and collaborating effectively for assay results that accelerate drug development.
-
Is Your Biologics CDMO Transparent?
12/12/2025
Transparency and collaboration with a CDMO are vital for reducing risk and protecting IP. Discover four essential practices, from clear communication to IP safeguards, that help build trust.
-
Optimizing qPCR For Broad-Range Transcript Detection In Anti-PD-1 Therapy
4/23/2025
Optimize qPCR protocols for greater sensitivity and reproducibility to accurately measure immune-related gene expression and better identify patients who will benefit from anti-PD-1 immunotherapy.
-
Transitioning From Using RUO To cGMP Chemicals For Clinical Trials
10/17/2023
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.
-
Complexing RNPs: Have You Established Your Clinical Acceptance Criteria?
5/13/2025
When using CRISPR-Cas proteins for gene editing, it’s critical to ensure consistency and quality at each stage of the manufacturing process. The FDA recommends establishing well-defined acceptance criteria for the RNP formation step.
-
Potent Immune Response With Vernal's LNP-mRNAs
4/26/2024
As mRNA medicine continues to evolve, understand how trusted manufacturing partners will continue to play a pivotal role in translating innovative concepts into clinical reality.
-
Analytical Method Release And Stability Platform For RNA Drug Substance
3/14/2025
We offer comprehensive analytical support across the R&D space, including method development, validation, process characterization, in-process testing, process validation, and GMP release testing.
-
Dispelling Common Clinical Trial Oversight Myths
6/17/2025
Many clinical trial oversight problems can be avoided or mitigated by sponsor understanding root causes and being a proactive collaborator with its partners.
-
Bridging The Skills Gap In Biopharma
6/3/2020
Employees must have the skills to effectively execute on process development and manufacturing operations. How do you ensure they are updated on complex bioprocessing techniques and technologies?
-
Shifting The Approach: 4 Tactics For ICH E6(R3) Implementation
4/30/2024
In addition to codifying some best practices, R3 recommends that sponsors adopt an approach to identifying and managing areas of risk to mitigate potential issues and enhance overall success.